A Systematic Review and Meta-Analysis of Cerebrospinal Fluid Amyloid and Tau Levels Identifies Mild Cognitive Impairment Patients Progressing to Alzheimer’s Disease

A Systematic Review and Meta-Analysis of Cerebrospinal Fluid Amyloid and Tau Levels Identifies Mild Cognitive Impairment Patients Progressing to Alzheimer’s Disease

Reported levels of amyloid-beta and tau in human cerebrospinal fluid (CSF) were evaluated to discover if these biochemical markers can predict the transition from Mild Cognitive Impairment (MCI) to Alzheimer’s disease (AD). A systematic review of the literature in PubMed and Web of Science (April 20...

Full description

Bibliographic Details
Main Authors: Yunxing Ma, Julia Brettschneider, Joanna F. Collingwood
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Biomedicines
Subjects:
Alzheimer’s disease
cerebrospinal fluid
tau
amyloid beta
mild cognitive impairment
biomarker
Online Access:https://www.mdpi.com/2227-9059/10/7/1713

Internet

https://www.mdpi.com/2227-9059/10/7/1713

Similar Items